Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 82
Plenary
HPV Vaccines: Progress To Date and Future Worldwide Directions
Douglas R. Lowy
National Cancer Institute, Bethesda, MD, United States
podium video slides video slides + audio mp3
from CROI 2014 on March 4, 2014 8:30 AM-9:00 AM
Plenary
HIV in People Who Use Drugs
Adeeba Kamarulzaman
University of Malaya, Kuala Lumpur, Malaysia
podium video slides video slides + audio mp3
from CROI 2014 on March 4, 2014 9:00 AM-9:30 AM
Oral Abstract: Hepatitis
Longitudinal Phenotypic Profiling of Early HCV-Specific CD4 T Cells in HIV- and HIV+ Individuals
Diana Y. Chen
Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
Rapid Peripheral In Vivo Cellular Changes During Interferon-Free Treatment of Hepatitis C
Eric G. Meissner
Laboratory of Immunoregulation, NIAID/NIH, Bethesda, MD, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
Faldaprevir Plus Pegylated Interferon Alfa-2a/Ribavirin in HIV/HCV Coinfection: STARTVerso4
Douglas Dieterich
Mount Sinai Medical Center, New York, NY, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
Simeprevir (TMC435) Plus PegIFN/Ribavirin in HCV Genotype-1/HIV-1 Coinfection (Study C212)
Douglas Dieterich
Icahn School of Medicine at Mount Sinai, New York, NY, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
All-Oral Combination of Daclatasvir, Asunaprevir, and BMS-791325 for HCV Genotype 1 Infection
Trevor Hawkins
Southwest CARE Center, Santa Fe, NM, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
Sofosbuvir Plus Ribavirin for HCV Genotype 1-3 Infection in HIV Coinfected Patients (PHOTON-1)
Susanna Naggie
Duke Clinical Research Institute, Durham, NC, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial
Anita Kohli
Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, United States and Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc. (formerly SAIC–Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
Daclatasvir in Combination With Simeprevir ± Ribavirin for Hepatitis C Virus Genotype 1 Infection
Christophe Hezode
Hôpital Henri Mondor, Paris, France
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Hepatitis
PEARL III: SVR ≥99% After 12 Wks of ABT-450/r/267 + ABT-333 ± RBV in Treatment Naïve HCV GT1b Infection
K Rajender Reddy
University of Pennsylvania, Philadelphia, PA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Host Factors and HIV/SIV Replication
Inhibition of Cul4A Neddylation Causes a Reversible Block To SAMHD1-Mediated Restriction of HIV-1
Henning Hofmann
NYU School of Medicine, New York, NY, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
MX2, an Interferon-Induced Inhibitor of HIV-1 Infection
Melissa Kane
The Rockefeller University, New York, NY, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner
Ruth Serra-Moreno
Harvard Medical School, Southborough, MA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
Crystal Structure of APOBEC3F Elucidates HIV-1 Vif Interaction and Dynamic Oligomerization
Markus-Frederik Bohn
Biochemistry, UMass Medical School, Worcester, MA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α
Owen Pornillos
Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
Global Identification of the RNA Targets of HIV-1 Gag During Particle Genesis
Sebla B. Kutluay
Aaron Diamond AIDS Research Center, New York, NY, United States
slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
Gorillas Transmitted SIV To Humans: Identification of HIV-1 Group P and O Ancestors
Mirela D'arc
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
A Gorilla Reservoir for Human T-lymphotropic Virus Type 4 (HTLV-4)
Walid Heneine
Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Host Factors and HIV/SIV Replication
Summary
Renate R. Köenig
Paul-Ehrlich-Institut, Langen, Germany
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
Moderator
Victor G. Valcour
University of California San Francisco, San Francisco, CA, United States
slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
Early Antiretroviral Therapy Appears To Normalize Intrathecal Markers of Immune Activation
Julia Peterson
Neurology, University of California San Francisco, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV
Michael J. Peluso
Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
Replication of HIV-1 in the Central Nervous System of Adults Early After Infection
Christa Buckheit Sturdevant
UNC Chapel Hill, Chapel Hill, NC, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
Persistent CSF, But Not Plasma HIV RNA Is Associated With Increased Risk of New-Onset Depression
Edward R. Hammond
The Johns Hopkins University, Baltimore, MD, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients With HAND
Edana Cassol
Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis
Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects
Ronald J. Ellis
University of California San Diego, San Diego, CA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility
Nikos Pantazis
Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Athens, Greece
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Transmission Clusters, Recent Infection and STIs Among New HIV Cases: Implications for Prevention
Hong-Ha M. Truong
University of California San Francisco, San Francisco, CA, United States and Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Race and Age Disparities in HIV Incidence and Prevalence Among MSM in Atlanta, GA
Eli S. Rosenberg
Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Correlating GSK1265744 Plasma Levels To Prevention of Rectal SHIV Transmission in Macaques
Chasity D. Andrews
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Monthly GSK744 Long-Acting Injections Protect Macaques Against Repeated Vaginal SHIV Exposures
J. Gerardo Garcia-Lerma
Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Safety and Pharmacokinetics/Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings
Beatrice A. Chen
University of Pittsburgh, Pittsburgh, PA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
FAME-02: A Phase I Trial To Assess Safety, PK, and PD of Gel and Film Formulations of Dapivirine
Katherine E. Bunge
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Single-Agent TDF Versus Combination FTC/TDF PrEP Among Heterosexual Men and Women
Jared Baeten
University of Washington, Seattle, WA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
Divergent Adherence Estimates With Pharmacokinetic and Behavioral Measures in VOICE (MTN003)
Ariane van der Straten
Women's Global Health Imperative, RTI International, San Francisco, CA, United States and Department of Medicine, Center for AIDS Prevention Studies (CAPS), University of California San Francisco, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Oral Abstract: Prevention and Epidemiology: Evolving Trends
HIV Transmission Risk Through Condomless Sex If HIV+ Partner On Suppressive ART: PARTNER Study
Alison Rodger
Research Department of Infection & Population Health, University College London, London, United Kingdom
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Themed Discussion: Acute HCV Infection
Discussion Leader
Georg M. Lauer
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Acute HCV Infection
Seminal HCV RNA Level May Mirror Dynamics of Plasma HCV RNA in HIV-Positive Men With Acute HCV
Daniel Bradshaw
Kirby Institute, University of New South Wales, Sydney, Australia
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Acute HCV Infection
Higher Risk of Sexually Acquired HCV Coinfection in MSM With Wide HIV Transmission Bottleneck
Roger D. Kouyos
University Hospital Zurich, University of Zurich, Zurich, Switzerland
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Acute HCV Infection
Assessing HCV Acquisition Routes in HIV-Infected MSM Using Single Genome Sequencing—A Pilot Study
Daniel S. Fierer
Infectious Diseases, Mount Sinai School of Medicine, New York, NY, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Acute HCV Infection
CD3+CD56+ Natural Killer-Like T Cells in HIV(+) Patients With Acute Hepatitis C
Pavlos Kokordelis
Internal Medicine I, University of Bonn, Bonn, Germany and German Center for Infection Research (DZIF), Bonn, Germany
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Acute HCV Infection
Questions and Answers
slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV
Discussion Leader
Wendy S. Post
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV
ST2 and GDF-15 Are Associated With Structural Heart Disease and Mortality in HIV
Eric Secemsky
University of California San Francisco, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV
Elevated NT-proBNP Levels Predict Mortality in HIV-Infected Women
Matthew R. Gingo
University of Pittsburgh, Pittsburgh, PA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV
Depression and HIV Are Risk Factors for Incident Heart Failure Among Veterans
Jessica R. White
University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV
Cardiac Steatosis Increased in HIV: Related To Gender, Visceral Fat and ARV Exposure
Julia B. Purdy
Critical Care Medicine, National Institutes of Health, Bethesda, MD, United States
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV
Questions and Answers
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
Themed Discussion: Response to Early ART Initiation in Infants
Discussion Leader
Mark F. Cotton
Stellenbosch University, Cape Town, South Africa
slides video slides + audio mp3
from CROI 2014 on March 4, 2014 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 82